
Pentoclove D 30mg/40mg Capsule SR
Marketer
Mediclove Biotech Pvt Ltd
Salt Composition
Domperidone (30mg) + Rabeprazole (40mg)
Overview Pentoclove D 30mg/40mg Capsule SR
Gastroesophageal reflux disease (GERD, or acid reflux) can be managed with Pentoclove D 30mg/40mg sustained-release capsules, a dual-action formulation. This medication alleviates common GERD symptoms like heartburn, stomach upset, and irritation by neutralizing stomach acid and facilitating gas expulsion. Dosage and duration of Pentoclove D 30mg/40mg SR are determined by your physician, taken on an empty stomach. Consistent use, as directed, is crucial; premature discontinuation may lead to symptom recurrence and disease exacerbation. Inform your doctor of all other medications you are using, as interactions are possible. Common, typically transient side effects include diarrhea, abdominal pain, dry mouth, headache, flatulence, and fatigue. Report any concerning side effects immediately. Due to potential drowsiness and dizziness, avoid driving or activities requiring alertness until the drug's effects are known. Alcohol consumption should be avoided as it can intensify drowsiness. Lifestyle changes, such as consuming cold milk and avoiding caffeinated beverages, spicy foods, and chocolate, may enhance treatment efficacy. Prior to commencing treatment, disclose any kidney or liver conditions, and inform your physician if you are pregnant, planning pregnancy, or breastfeeding.
Primary Ingredients of Pentoclove D 30mg/40mg Capsule SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Pentoclove D 30mg/40mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Pentoclove D 30mg/40mg Capsule SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire capsule without chewing, crushing, or breaking it. Administer Pentoclove D 30mg/40mg sustained-release capsules on an empty stomach.
Common Side effects of Pentoclove D 30mg/40mg Capsule SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Pentoclove D 30mg/40mg Capsule SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire capsule without crushing, chewing, or breaking it. Administer Pentoclove D 30mg/40mg Extended-Release Capsules on an empty stomach.
How Pentoclove D 30mg/40mg Capsule SR works:
Pentoclove D 30mg/40mg sustained-release capsules contain domperidone and rabeprazole, two active pharmaceutical ingredients. Domperidone, a prokinetic agent, enhances gastrointestinal motility, facilitating efficient food passage through the stomach. Rabeprazole, a proton pump inhibitor (PPI), decreases gastric acid secretion, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining alcohol and Pentoclove D 30mg/40mg sustained-release capsules. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Pentoclove D 30mg/40mg sustained-release capsules during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Pentoclove D 30mg/40mg capsule is likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Pentoclove D 30mg/40mg sustained-release capsules might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Pentoclove D 30mg/40mg sustained-release capsules. Dosage modification of Pentoclove D 30mg/40mg sustained-release capsules may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Pentoclove D 30mg/40mg SR capsules cautiously, potentially requiring dose modification. Medical advice is essential. Pentoclove D 30mg/40mg SR capsules are contraindicated for individuals with moderate to severe hepatic dysfunction.
What if you forget to take Pentoclove D 30mg/40mg Capsule SR :
Should you forget a Pentoclove D 30mg/40mg sustained-release capsule, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Pentoclove D 30mg/40mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
